Journal
PHARMACEUTICALS
Volume 15, Issue 7, Pages -Publisher
MDPI
DOI: 10.3390/ph15070862
Keywords
water-soluble; ruthenium; cyclopentadienyl; anticancer; albumin
Categories
Funding
- Fundacao para a Ciencia e Tecnologia (FCT), I.P./MCTES [PTDC/QUI-QIN/0146/2020, UIDB/00100/2020, LA/P/0056/2020, UID/Multi/04349/2019]
- FCT [CEECIND/00630/2017]
- Fundação para a Ciência e a Tecnologia [UID/Multi/04349/2019, PTDC/QUI-QIN/0146/2020] Funding Source: FCT
Ask authors/readers for more resources
New water-soluble Ru(II) organometallic complexes with potential anticancer activity were synthesized and characterized. These complexes showed promising antiproliferative potential on breast adenocarcinoma, ovarian carcinoma, and colorectal adenocarcinoma cell lines. Additionally, their interaction with human serum albumin was evaluated, highlighting their ability to strongly quench the intrinsic fluorescence of albumin.
Ruthenium complexes are emerging as one of the most promising classes of complexes for cancer therapy. However, their limited aqueous solubility may be the major limitation to their potential clinical application. In view and to contribute to the progress of this field, eight new water-soluble Ru(II) organometallic complexes of general formula [RuCp(mTPPMS)(n)(L)] [CF3SO3], where mTPPMS = diphenylphosphane-benzene-3-sulfonate, for n = 2, L is an imidazole-based ligand (imidazole, 1-benzylimidazole, 1-butylimidazole, (1-(3-aminopropyl)imidazole), and (1-(4-methoxyphenyl)imidazole)), and for n = 1, L is a bidentate heteroaromatic ligand (2-benzoylpyridine, (di(2-pyridyl)ketone), and (1,2-(2-pyridyl)benzo-[b]thiophene)) were synthesized and characterized. The new complexes were fully characterized by NMR, FT-IR, UV-vis., ESI-HRMS, and cyclic voltammetry, which confirmed all the proposed molecular structures. The antiproliferative potential of the new Ru(II) complexes was evaluated on MDAMB231 breast adenocarcinoma, A2780 ovarian carcinoma, and HT29 colorectal adenocarcinoma cell lines, showing micromolar (MDAMB231 and HT29) and submicromolar (A2780) IC50 values. The interaction of complex 6 with human serum albumin (HSA) and fatty-acid-free human serum albumin (HSA(faf)) was evaluated by fluorescence spectroscopy techniques, and the results revealed that the ruthenium complex strongly quenches the intrinsic fluorescence of albumin in both cases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available